Dallah Healthcare Company
TADAWUL:4004.SR
154.8 (SAR) • At close November 7, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) SAR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operationele Activiteiten: | |||||||||||||
Nettowinst
| 400.315 | 329.134 | 291.838 | 113.546 | 151.626 | 145.3 | 305.151 | 225.832 | 165.057 | 147.115 | 136.633 | 133.36 | 113.401 |
Afschrijvingen & Amortisatie
| 125.615 | 114.264 | 115.114 | 95.085 | 92.666 | 74.503 | 59.742 | 57.501 | 56.303 | 45.04 | 36.123 | 28.864 | 25.507 |
Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Verandering in Werkkapitaal
| -42.977 | -117.467 | -128.429 | -75.446 | 36.37 | -37.852 | -21.531 | -17.713 | -49.833 | -102.017 | -106.274 | -73.349 | -36.935 |
Vorderingen
| -76.351 | -57.922 | -96.777 | -156.065 | 12.347 | -44.539 | -22.049 | -59.106 | -29.268 | -29.516 | -88.592 | -65.508 | 0 |
Voorraden
| 30.46 | -38.695 | -52.21 | -18.965 | -15.7 | -11.474 | -12.35 | -6.543 | 0.68 | -36.14 | -21.307 | -3.192 | 1.61 |
Crediteuren
| 6.818 | 25.936 | 29.246 | 35.889 | 32.936 | 11.676 | 19.84 | 5.37 | -4.695 | 0 | 0 | 0 | 0 |
Overig Werkkapitaal
| -3.904 | -46.786 | -8.687 | 63.694 | 6.787 | -26.379 | -9.181 | -11.17 | -50.513 | -65.877 | -84.967 | -70.156 | -38.544 |
Overige Niet-Contante Posten
| 142.83 | 116.2 | 83.026 | 50.117 | 26.465 | 22.73 | 9.708 | 75.951 | 42.787 | 59.298 | 40.421 | 36.135 | 26.067 |
Kasstroom uit Operationele Activiteiten
| 625.784 | 442.131 | 361.549 | 183.301 | 307.127 | 204.68 | 353.07 | 341.571 | 214.314 | 149.437 | 106.904 | 125.011 | 128.041 |
Investeringsactiviteiten: | |||||||||||||
Investeringen in Materiële Vaste Activa
| -296.658 | -174.995 | -115.69 | -129.653 | -201.062 | -256.083 | -431.421 | -316.357 | -193.469 | -235.183 | -455.757 | -86.388 | -72.18 |
Netto Overnames
| 1.261 | -56.263 | -21.847 | -276.686 | 0.029 | -5.98 | 0.648 | 0.001 | -141.9 | 0 | -5.091 | 0 | 0.659 |
Aankoop van Beleggingen
| 0 | -0.283 | -291.959 | -23.331 | -22.321 | -5.98 | 0 | 0 | -0.383 | -0.115 | -208.125 | 0 | 0 |
Verkoop/verval van Beleggingen
| 0 | 0 | 0.07 | 0.28 | 2.437 | 27.752 | 18.994 | 68.366 | 3.422 | 100 | 0 | 0 | 0 |
Overige Investeringsactiviteiten
| 1.712 | 5.608 | 4.125 | 1.856 | -19.855 | 0.025 | 0.648 | 0.001 | -3.155 | 0.259 | 1.191 | 0.145 | 0.005 |
Kasstroom uit Investeringsactiviteiten
| -293.685 | -225.934 | -425.3 | -427.534 | -220.918 | -234.286 | -411.779 | -247.99 | -335.486 | -135.039 | -662.691 | -86.243 | -71.516 |
Financieringsactiviteiten: | |||||||||||||
Schuldaflossingen
| -273.872 | -656.688 | -378.162 | -427.911 | -583.984 | -2,314.002 | -2,011.487 | -1,583.606 | -1,451.088 | -537.048 | 0 | -72.019 | 0 |
Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 519.347 | 0 |
Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | -190.453 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Uitgekeerde Dividenden
| -146.522 | -180 | -162.5 | -99.882 | -123.87 | -147.5 | -118 | -88.5 | -47.2 | -70.8 | -70.8 | -6.479 | -105.114 |
Overige Financieringsactiviteiten
| 93.413 | 650.356 | 681.847 | 814.344 | 854.065 | 2,447.027 | 2,092.08 | 1,671.679 | 1,647.819 | 608.517 | 115.918 | -4.113 | 66.767 |
Kasstroom uit Financieringsactiviteiten
| -334.736 | -186.332 | 141.185 | 286.551 | -44.242 | -14.475 | -37.407 | -0.427 | 149.531 | 0.669 | 45.118 | 436.736 | -38.347 |
Overige Informatie: | |||||||||||||
Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.168 | 0 | 0 |
Netto Kasstroomverandering
| -2.637 | 29.866 | 77.435 | 42.318 | 41.967 | -44.081 | -96.116 | 93.154 | 28.359 | 15.067 | -510.501 | 475.504 | 18.177 |
Kaspositie aan het Einde van de Periode
| 235.308 | 237.945 | 208.079 | 130.644 | 88.326 | 46.359 | 90.44 | 186.557 | 93.403 | 65.044 | 49.977 | 560.478 | 84.973 |